Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-22

FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved ANI Pharmaceuticals' supplemental application for fluphenazine hydrochloride, a generic antipsychotic used to treat schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluphenazine hydrochloride (Fluphenazine hydrochloride)

Snippet

SUPPL AP for FLUPHENAZINE HYDROCHLORIDE (FLUPHENAZINE HYDROCHLORIDE)